Igenomix Middle East +971 4 5519465
Request information
Request information

Contact




EJPPZU

Thank you for your email. We´ll contact you shortly.

Advanced Reproductive Genetic Services

We work to help you and your partner through your path towards reproductive success

featured services

CGT

A simple blood test prior to pregnancy which prevents genetic disorders in the baby

Baby Gender

The best choice for gender selection

PGD

Prevent the transmission of single gene disorders in a family and achieve a healthy pregnancy

PGS

Improve the chances of reproductive success with Next-Generation Sequencing for PGS

NACE

Non-invasive prenatal test alternative to amniocentesis

ERA

If you have had implantation failure, we can help you

POC

Detect the cause for lost pregnancy by analyzing the fetal tissue

SAT

Sperm Aneuploidy Test. 5 chromosomes: 13, 18, 21, X and Y

We offer our services worldwide

Select your country to visit its website

why igenomix

  1. More than 15 years’ experience

  2. Our expert team supports the work of reproductive medicine professionals

  3. Guaranteed outstanding customer service

  4. State of the art technology: Arrays, PCR, NGS

  5. High level of investment in R&D

  6. Worldwide presence: 8 labs

  7. We participate in research projects with world known entities on an international level

  8. Robust and reliable diagnosis

  9. All-in-one genetic supplier

View all

what we've been up to

Our CSO Prof. Carlos Simon opens ESHRE’s Annual Meeting in Geneva

22 June, 2017

This year’s Human Reproduction keynote lecture, which will open ESHRE’s Annual Meeting in Geneva, will be given by our CSO Prof. Carlos Simón, who will address one of the biggest audiences […]

read more

IGENOMIX at ESHRE 2017

21 June, 2017

IGENOMIX at ESHRE 2017 From 2 – 5 July at Palexpo venue, Geneva, Switzerland. IGENOMIX will be taking part in this year’s ESHRE Annual Meeting, held at the Palexpo venue […]

read more

IGENOMIX receives EMA Orphan Drug Designation for its product indicated for Asherman’s Syndrome with Asphalion support

20 June, 2017

We are proud to announce that our product autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells (IGX1) was granted the Orphan Drug Designation (ODD) on March 15th 2017 by […]

read more